FDA Adverse Event Injury Summary report: N

FLEXTEND II

MDR report key: 3210115 · Received July 8, 2013

Report

Report Number
2124215-2013-06191
Event Type
Injury
Date Received
July 8, 2013
Date of Event
April 13, 2013
Report Date
April 13, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
PMA / PMN Number
NOTAPVD
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE RIGHT ATRIAL (RA) AND RIGHT VENTRICULAR (RV) LEAD REMAIN IN SERVICE AND THEREFORE; WILL NOT BE RETURNED FOR ANALYSIS. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED AND AN AMENDED REPORT SUBMITTED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT POST IMPLANT, THIS RIGHT VENTRICULAR (RV) AND RIGHT ATRIAL (RA) LEAD DISLODGED. A REVISION PROCEDURE WAS PERFORMED; AND THE LEADS WERE SUCCESSFULLY REPOSITIONED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
310465 FLEXTEND II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4097

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L| R